See also this year's filing and all EDGAR filings for this company.
PDF Report 0001467652_2019_Neos_Therapeutics_Inc.pdf
Logs
| warning | Missing logo | subcommand.report | {} |
| info | Failed to set obs_EconomicCapitalRatio | industry.us_generic | {'reason': "KeyError('0001467652')"} |
| info | Added remainder_ComprehensiveNetIncome directly from 10K | industry.us_generic | {} |
Graph
Absolute values for 0001467652, Neos Therapeutics Inc.
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 88,678,000 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 14,616,000 |
| 2 | PropertyPlantAndEquipmentNet | 7,914,000 |
| 3 | remainder_Assets | 149,000 |
| 4 | LiabilitiesCurrent | 57,105,000 |
| 5 | LiabilitiesNoncurrent | 46,407,000 |
| 6 | remainder_Liabilities | 0 |
| 7 | CostOfGoodsAndServicesSold | 26,928,000 |
| 8 | SellingGeneralAndAdministrativeExpense | 13,915,000 |
| 9 | ResearchAndDevelopmentExpense | 8,508,000 |
| 10 | remainder_Expenses | 53,107,000 |
| 11 | remainder_Revenues | 49,988,000 |
| 12 | remainder_NetIncome | 795,000 |
| 13 | remainder_ComprehensiveNetIncome | 6,000 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 111,357,000 |
| 1 | Liabilities | 103,512,000 |
| 2 | Expenses | 102,458,000 |
| 3 | Revenues | 49,988,000 |
| 4 | StockholdersEquity | 7,845,000 |
| 5 | NetIncome | -51,675,000 |
| 6 | ComprehensiveNetIncome | -51,672,000 |
| 7 | BaseVar | 184,058,000 |
| 8 | EconomicCapitalRatio | -0.355 |